Journal
NEUROPHARMACOLOGY
Volume 197, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2021.108728
Keywords
Blood-brain barrier; Crosstalk; Insulin; Irisin; Cytokines; Extracellular vesicles; Exosomes
Categories
Funding
- Webber Endowment in Alzheimer's Research Fund
- Brazilian funding agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [467546/2014-2]
- Brazilian funding agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [202.944/2015]
- National Institute of Translational Neuroscience (INNT/Brazil) [465346/2014-6]
Ask authors/readers for more resources
This article explores the impact of molecules in the peripheral circulation on cognitive function, specifically examining how they can reach the brain and interact with it through various pathways. Understanding the mechanisms of blood-borne molecule transport to the CNS is crucial for developing minimally invasive strategies to deliver therapeutic drugs for neurological disorders.
Mounting evidence indicates that signaling molecules identified primarily in the peripheral circulation can affect cognitive function in physiological and pathological conditions, including in the development of several neurological diseases. However, considering the properties of the vascular blood-brain barrier (BBB), circulating lipophobic molecules would not be expected to cross this vascular structure. Thus, if and how peripheral lipophobic molecules, such as hormones and cytokines, reach the brain to exert their reported effects remains to be better established. In this review, we will discuss evidence for and against the ability of molecules in the circulation, such as insulin, cytokines, and irisin to reach the brain and mediate the crosstalk between peripheral tissues and the central nervous system (CNS). We hypothesize that in addition to entering the brain via receptor mediated transcytosis, these circulating molecules can have their transport facilitated by extracellular vesicles or under pathological conditions when the BBB is disrupted. We also discuss the possibility that these circulating molecules access the brain by acting directly on circumventricular organs, which lack the BBB, by local synthesis in the choroid plexus, and via activation of afferent vagal nerves. Advancing the understanding of mechanisms implicated in the transport of blood-borne molecules to the CNS will help us elucidate the contribution of peripheral factors to brain health and disease, and will enable the development of minimally invasive strategies to deliver therapeutic drugs to the brain in neurological disorders. This article is part of the special Issue on 'Cross Talk between Periphery and the Brain'.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available